
Poster 40
The Role of the EHR in Newborn Sequencing Projects
Presenter: Brooke Greenstein

Poster 39
FirstSteps: The newborn genome initiative in Greece
Presenter: Dr Petros Tsipouras
Poster 38
Use of Whole Genome Sequencing to Screen 100,000 Newborns for Treatable Genetic Disorders
Presenter: Alice Tuff-Lacey

Poster 37
The Screen4Care project: defining genetic newborn screening operational pipeline and ethical issues to run a large genomic screening pilot study in EU countries
Presenter: Dr Alessandra Ferlini

Poster 36
The Clinician-reported Genetic testing Utility InDEx for Newborn Screening (C-GUIDE NBSeq): Development and content validity
Presenter: Dr Salma Shickh

Poster 35
Psychosocial impact analysis in PERIGENOMED: example of a mixed design developed through collective intelligence
Presenter: Camille Level

Poster 34
Phenotype Associations from a Comprehensive Database of Long-Chain Fatty Acid Oxidation Disorder Gene Variants
Presenter: Dr Nicole Miller

Poster 33
A collaborative working group of experts to define the list of diseases to be screened in the French genomic newborn screening project PERIGENOMED
Presenter: Dr Laurence Faivre

Poster 32
Parental Perspectives on the Implications of Expanded and Universal Newborn Screening
Presenter: Nicole Kelly

Poster 31
NGS-technologies in the Dutch newborn bloodspot screening “CRADLE-Study” – ICoNS’24
Presenter: Els Voorhoeve

Poster 30
Newborn sequencing using comprehensive genome analysis across racial and ethnic groups: Results from the BabySeq Project
Presenter: Rose Heald

Poster 29
Infants with carrier status in BabySeq and Comparison to other Carrier Screening
Presenter: Dr José Manuel González de Aledo Castillo

Poster 28
Implementing BeginNGS using prequalified genomic newborn screening analyses: lessons learned from retrospective and exploratory prospective studies
Presenter: Dr Meredith Wright

Poster 27
Genome Screening of Newborns: what can we find and what’s next?
Presenter: Dr Jorune Balciuniene

Poster 26
GEN SEQ TRAIL: Genomic Newborn Sequencing: Therapy Ready And Information for Life (TRAIL)
Presenter: Shelley Pirreca

Poster 25
From Feasibility to Framework: Advancing Genomic Newborn Screening through Technical Feasibility and Ethical Considerations in Germany
Presenter: Dr Heiko Brennenstuhl

Poster 24
Exploring the feasibility, acceptability and impact of genomic newborn screening for rare diseases in England: A Process and Impact Evaluation of the Generation Study
Presenter: Dr James Buchanan

Poster 23
Ethical Challenges in Newborn Genomic Sequencing: Assessing Investigators’ Perspectives
Presenter: Dr Hadley Stevens Smith

Poster 22
digitalMLPA complements sequence analysis with the detection of CNVs, complex regions, F8 inversions and methylation changes in Fragile X and imprinting disorders
Presenter: Dr Joery den Hoed

Poster 21
Development and analytical validity assessment of bioinformatics solution for genomic newborn screening in the Generation Study
Presenter: Dr Dalia Kasperaviciute

Poster 20
Design, implementation and validation of a genetic newborn screening study for multiple rare diseases: the "Genoma-Puglia" project
Presenter: Dr Mattia Gentile


Poster 18
Patient-Driven Partnership: Developing a Gene Panel for Actionable Conditions for Newborn Screening Using a Collaborative Approach
Presenter: Dr Gulcin Gumus
Poster 17
Considerations for the expansion of NBS programmes: insights from the Rare Barometer survey on opinion of people living with a rare disease
Presenter: Dr Gulcin Gumus

Poster 16
Blockchain-Enabled Family Vaults: A Global and Enduring Framework for Newborn Genomic Data Governance
Presenter: Daniel Uribe